MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells

Stem Cells

Volumn 32, Issue 4, 2014, Pages 902-912

  Chen, Li ^a   HolmstrØm, Kim ^b   Qiu, Weimin ^a   Ditzel, Nicholas ^a   Shi, Kaikai ^a   Hokland, Lea ^a   Kassem, Moustapha ^a,c  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b BIONEER A S   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

DifferentiationBone formation; Human stromal stem cells; MicroRNA 34a; Osteoblast

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; JAGGED1; MICRORNA 34A; NOTCH1 RECEPTOR; TRANSCRIPTION FACTOR E2F; CALCIUM BINDING PROTEIN; CELL CYCLE PROTEIN; MEMBRANE PROTEIN; MICRORNA; MIRN34 MICRORNA, HUMAN; NOTCH1 PROTEIN, HUMAN; SERRATE PROTEINS; SIGNAL PEPTIDE;

ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; IN VIVO STUDY; OSSIFICATION; OSTEOBLAST; PREDICTIVE VALUE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BONE DEVELOPMENT; CYTOLOGY; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MESENCHYMAL STROMAL CELLS; MICRORNAS; OSTEOBLASTS; OSTEOGENESIS; RECEPTOR, NOTCH1;

EID: 84896373668     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1615     Document Type: Article

References (49)

1. Marie PJ, Kassem M,. Osteoblasts in osteoporosis: Past, emerging, and future anabolic targets. Eur J Endocrinol 2011; 165: 1-10.
2. Kassem M, Marie PJ,. Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. Aging Cell 2011; 10: 191-197.
3. Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science (New York, Ny) 2004; 303: 83-86.
4. Cuellar TL, McManus MT,. MicroRNAs and endocrine biology. J Endocrinol 2005; 187: 327-332.
5. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432: 226-230.
6. Wilfred BR, Wang WX, Nelson PT,. Energizing miRNA research: A review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007; 91: 209-217.
7. Pillai RS, Bhattacharyya SN, Filipowicz W,. Repression of protein synthesis by miRNAs: How many mechanisms Trends Cell Biol 2007; 17: 118-126.
8. Bartel DP,. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
9. He L, Hannon GJ,. MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev 2004; 5: 522-531.
10. Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 2005; 433: 769-773.
11. Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
12. Taipaleenmaki H, Bjerre Hokland L, Chen L, et al. Mechanisms in endocrinology: Micro-RNAs: Targets for enhancing osteoblast differentiation and bone formation. Eur J Endocrinol 2012; 166: 359-371.
13. Li Z, Hassan MQ, Volinia S, et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA 2008; 105: 13906-13911.
14. Huang J, Zhao L, Xing L, et al. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells (Dayton, Ohio) 28: 357-364.
15. Eskildsen T, Taipaleenmaki H, Stenvang J, et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci USA 108: 6139-6144.
16. Zhang JF, Fu WM, He ML, et al. MiR-637 maintains the balance between adipocytes and osteoblasts by directly targeting Osterix. Mol Biol Cell 2011; 22: 3955-3961.
17. Simonsen JL, Rosada C, Serakinci N, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002; 20: 592-596.
18. Burns JS, Rasmussen PL, Larsen KH, et al. Parameters in three-dimensional osteospheroids of telomerized human mesenchymal (stromal) stem cells grown on osteoconductive scaffolds that predict in vivo bone-forming potential. Tissue Eng 2010; 16: 2331-2342.
19. Saeed AI, Sharov V, White J, et al. TM4: A free, open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374-378.
20. Gregory CA, Gunn WG, Peister A, et al. An Alizarin red-based assay of mineralization by adherent cells in culture: Comparison with cetylpyridinium chloride extraction. Anal Biochem 2004; 329: 77-84.
21. Stenderup K, Rosada C, Justesen J, et al. Aged human bone marrow stromal cells maintaining bone forming capacity in vivo evaluated using an improved method of visualization. Biogerontology 2004; 5: 107-118.
22. Abdallah BM, Ditzel N, Kassem M,. Assessment of bone formation capacity using in vivo transplantation assays: Procedure and tissue analysis. Methods Mol Biol (Clifton, NJ) 2008; 455: 89-100.
23. Lian JB, Stein GS, van Wijnen AJ, et al. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 2012; 8: 212-227.
24. Kuhn DE, Martin MM, Feldman DS, et al. Experimental validation of miRNA targets. Methods (San Diego, CA) 2008; 44: 47-54.
25. Fujita Y, Kojima K, Hamada N, et al. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells. Biochem Biophys Res Commun 2008; 377: 114-119.
26. Hermeking H,. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17: 193-199.
27. Pulikkan JA, Peramangalam PS, Dengler V, et al. C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood 2010; 116: 5638-5649.
28. Tazawa H, Tsuchiya N, Izumiya M, et al. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007; 104: 15472-15477.
29. Toyota M, Suzuki H, Sasaki Y, et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008; 68: 4123-4132.
30. Wei J, Shi Y, Zheng L, et al. miR-34s inhibit osteoblast proliferation and differentiation in the mouse by targeting SATB2. J Cell Biol 2012; 197: 509-521.
31. Bommer GT, Gerin I, Feng Y, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007; 17: 1298-1307.
32. He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134.
33. Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743.
34. Tarasov V, Jung P, Verdoodt B, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: MiR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007; 6: 1586-1593.
35. Christoffersen NR, Shalgi R, Frankel LB, et al. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 2010; 17: 236-245.
36. Ichimura A, Ruike Y, Terasawa K, et al. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol Pharmacol 2010; 77: 1016-1024.
37. Chang TC, Wentzel EA, Kent OA, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-752.
38. Krantz ID, Piccoli DA, Spinner NB,. Alagille syndrome. J Med Genet 1997; 34: 152-157.
39. Kung AW, Xiao SM, Cherny S, et al. Association of JAG1 with bone mineral density and osteoporotic fractures: A genome-wide association study and follow-up replication studies. Am J Hum Genet 2010; 86: 229-239.
40. Guarnaccia C, Pintar A, Pongor S,. Exon 6 of human Jagged-1 encodes an autonomously folding unit. FEBS Lett 2004; 574: 156-160.
41. Li H, Yu B, Zhang Y, et al. Jagged1 protein enhances the differentiation of mesenchymal stem cells into cardiomyocytes. Biochem Biophys Res Commun 2006; 341: 320-325.
42. Rodilla V, Villanueva A, Obrador-Hevia A, et al. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc Natl Acad Sci USA 2009; 106: 6315-6320.
43. Bae Y, Yang T, Zeng HC, et al. miRNA-34c regulates Notch signaling during bone development. Hum Mol Genet 2012; 21: 2991-3000.
44. Li Y, Guessous F, Zhang Y, et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 2009; 69: 7569-7576.
45. Bu P, Chen KY, Chen JH, et al. A microRNA miR-34a-regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell 2013; 12: 602-615.
46. Janssen HL, Reesink HW, Lawitz EJ, et al. Treatment of HCV Infection by Targeting MicroRNA. New Engl J Med 2013; 368: 1685-1694.
47. Inose H, Ochi H, Kimura A, et al. A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci USA 2009; 106: 20794-20799.
48. Li H, Xie H, Liu W, et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J Clin Investig 2009; 119: 3666-3677.
49. Andersen MO, Nygaard JV, Burns JS, et al. siRNA nanoparticle functionalization of nanostructured scaffolds enables controlled multilineage differentiation of stem cells. Mol Therapy 2010; 18: 2018-2027.